Literature DB >> 33518015

Liver and Gastrointestinal Involvement: Update.

Michael Rosenzweig1, Efstathios Kastritis2.   

Abstract

The organs affected most commonly by AL amyloidosis are the kidneys and heart, however, liver and gastrointestinal (GI) tract are also commonly affected. Symptoms of GI amyloidosis often mimic those of other GI disorders; having a keen awareness of the need to evaluate for amyloidosis is critical in avoiding delay in diagnosis and intervention. GI and liver involvement is associated with significant complications, and challenges in symptomatic management. As with all AL-related organ disease, early systemic treatment can prevent progression of tissue damage and improve outcomes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alkaline Phosphatase; Bilirubin; Gastrointestinal involvement; Light chain (AL) amyloidosis; Liver (hepatic) amyloidosis

Year:  2020        PMID: 33518015     DOI: 10.1016/j.hoc.2020.11.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  1 in total

1.  A population-based cohort study of the epidemiology of light-chain amyloidosis in Taiwan.

Authors:  Hsin-An Hou; Chao-Hsiun Tang; Choo Hua Goh; Shih-Pei Shen; Kuan-Chih Huang; Hong Qiu; Sarah Siggins; Lee Anne Rothwell; Yanfang Liu
Journal:  Sci Rep       Date:  2022-09-21       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.